Vincent Santucci

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

Xavier Emonds‐Alt, Jean-Daniel Doutremepuich, Michel Héaulme et al. · European Journal of Pharmacology · 1993 · 373 citations

Signal Transduction, Vivo Biological Activities, Medicine +8

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Philippe Pichat, Olivier Bergis, Jean-Paul Terranova et al. · Neuropsychopharmacology · 2006 · 237 citations · Full text

Psychiatry, Psychotic Disorder, Medicine +10

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne‐Bouhtou et al. · Neuropsychopharmacology · 2005 · 217 citations · Full text

Neurophysiology, Medicine, Glycine Transporter-1 Ssr504734 +12

Biochemical and Pharmacological Activities of SR 142948A, a New Potent Neurotensin Receptor Antagonist

Danielle Gully, Bernard Labeeuw, Robert Boigegrain et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 214 citations · Full text

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

Bruno Biton, Olivier Bergis, Frédéric Galli et al. · Neuropsychopharmacology · 2006 · 175 citations · Full text

Molecular Pharmacology, Functional Profile, Medicine +6